List of works by Adil Daud

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

scientific article published on 8 December 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

scientific article published oln 16 November 2016

A Review of Novel Intralesional Therapies for Melanoma, With an Emphasis on a Potential Combination Approach

scientific article published on May 2016

A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments

scientific article published on 25 June 2018

A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors

scientific article published on 06 August 2008

A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma

scientific article

A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAF V600E mutation-positive metastatic melanoma

scientific article

A randomised controlled study on the use of finishing and polishing systems on different resin composites using 3D contact optical profilometry and scanning electron microscopy.

scientific article published on 19 January 2018

A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma.

scientific article published on 15 January 2015

ASO Author Reflections: Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma

scientific article published on 02 June 2020

Activated Stat-3 in Melanoma

scientific article published on 01 July 2008

An analysis of genetic heterogeneity in untreated cancers

scientific article published on 27 August 2019

An isolated Merkel cell carcinoma metastasis at a distant cutaneous site presenting as a second 'primary' tumor.

scientific article published on 23 August 2011

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

scientific article (publication date: 20 September 2014)

Applying the WHO conceptual framework for the International Classification for Patient Safety to a surgical population

scientific article published on 23 January 2016

Association Between Body Mass Index and Cardiometabolic Risks Among Malay Obese Adults.

scientific article

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

scientific article published on April 2016

BEAM trial: lighting the way ahead?

scientific article published on 28 November 2011

Beyond BRAF in melanoma.

scientific article published on January 2012

Changes in Dendritic Cell Phenotype After a New High-dose Weekly Schedule of Interleukin-2 Therapy for Kidney Cancer and Melanoma ⬇️

scientific article published on October 1, 2010

Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial

scientific article published on 18 November 2014

Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I/II trial of valproic acid and epirubicin/FEC.

scientific article

Clinical outcomes and quality of life in recipients of livers donated after cardiac death

scientific article

Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies

scientific article published on 17 August 2016

Colon targeted curcumin delivery using guar gum.

scientific article published on June 2010

Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study

scientific article published on 15 July 2014

Combinatorial approach to treatment of melanoma

scientific article published on June 2014

Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor

scientific article

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer.

scientific article

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

scientific article

Combined dabrafenib and trametinib therapy in metastatic melanoma and organ transplantation: Case report and review of the literature

scientific article published on 24 November 2015

Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo

scientific article

Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma

scientific article

Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial

scientific article published on 05 October 2020

Current and Emerging Perspectives on Immunotherapy for Melanoma.

scientific article

Cutaneous melanoma: prognostic factors

scientific article

Detection of medical errors in kidney transplantation: a pilot study comparing proactive clinician debriefings to a hospital-wide incident reporting system.

scientific article

Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity.

scientific article

Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity

scientific article

Dual MEK/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanoma.

scientific article published on 16 September 2017

Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma

scientific article published on 28 December 2017

Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program.

scientific article published on November 2017

Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial

scientific article

Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III.

scientific article published on 7 December 2017

Emerging biomarkers as predictors to anti-PD1/PD-L1 therapies in advanced melanoma

scientific article published on June 2016

Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab

scientific article published on 07 March 2016

Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy

scientific article published on 21 March 2017

Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer

scientific article published on 17 July 2020

Extended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in BRAF-Mutant Melanoma

scientific article published on 15 November 2019

Future of combination therapy with dabrafenib and trametinib in metastatic melanoma

scientific article published on 02 September 2015

Gastrointestinal: Atrioesophageal fistula.

scientific article published on 10 May 2016

Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma

scientific article

In vitro evaluation of Moringa oleifera gum for colon-specific drug delivery.

scientific article

In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series.

scientific article

Increased FDG avidity in lymphoid tissue associated with response to combined immune checkpoint blockade

scientific article published on 20 September 2016

Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients

scientific article published on 4 January 2017

Inhibitors of Cytotoxic T Lymphocyte Antigen 4 and Programmed Death 1/Programmed Death 1 Ligand for Metastatic Melanoma, Dual Versus Monotherapy-Summary of Advances and Future Directions for Studying These Drugs.

scientific article published on January 2017

Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma

scientific article published on 03 October 2019

Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses

scientific article published on 18 December 2019

Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100).

scientific article published on 15 January 2015

Involution of eruptive melanocytic nevi on combination BRAF and MEK inhibitor therapy.

scientific article

Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research

scientific article

Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC.

scientific article published on 14 April 2017

Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib

scientific article published on 9 October 2017

Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma

scientific article published on 15 January 2015

MIIB: A Metric to Identify Top Influential Bloggers in a Community.

scientific article published on 28 September 2015

Management of Treatment-Related Adverse Events with Agents Targeting the MAPK Pathway in Patients with Metastatic Melanoma

scientific article published on 18 May 2017

Management of a patient with advanced BRAF-mutant melanoma.

scientific article

Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies.

scientific article

Melanoma

scientific article published on 01 March 2012

Melanoma immunotherapy

scientific article published on 20 March 2014

Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid).

scientific article published on 24 October 2017

Melanoma, version 2.2013: featured updates to the NCCN guidelines

scientific article published in April 2013

Melanoma: promising new discoveries and treatment modalities for difficult clinical scenarios

scientific article published on 01 July 2008

NRAS-mutant melanoma: response to chemotherapy.

scientific article

New horizons in melanoma treatment: targeting molecular pathways

scientific article

Nivolumab plus ipilimumab in the treatment of advanced melanoma.

scientific article published on 31 October 2015

Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib.

scientific article

Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial.

scientific article

P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study.

scientific article published on July 2015

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

scientific article

PD-1 and PD-L1 antibodies for melanoma

scientific article

Part I: Checkpoint inhibitors in cancer therapy.

scientific article published in June 2016

Part II: Checkpoint inhibitors in cancer therapy

scientific article

Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy

scientific article

Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC).

scientific article published on 6 November 2014

Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression.

scientific article published on 29 July 2015

Pembrolizumab for melanoma- safety profile and future trends

scientific article

Pembrolizumab versus Ipilimumab in Advanced Melanoma

scientific article (publication date: 25 June 2015)

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

scientific article

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).

scientific article

Pharmacogenetics of drug-induced birth defects: the role of polymorphisms of placental transporter proteins.

scientific article

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma.

scientific article

Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors.

scientific article published on 14 May 2015

Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.

scientific article published on 29 September 2008

Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma

scientific article published on 29 November 2011

Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.

scientific article

Phase I study of bosutinib, a src/abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors.

scientific article

Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignancies

scientific article

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma

scientific article

Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies

scientific article

Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker.

scientific article published on 08 September 2009

Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours

scientific article published on 20 October 2017

Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma.

scientific article published on December 2008

Phase II trial of karenitecin in patients with malignant melanoma: clinical and translational study

scientific article

Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma

scientific article

Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor

scientific article published on 01 July 2008

Plasmid IL-12 electroporation in melanoma.

scientific article

Preclinical and clinical activity of the topoisomerase I inhibitor, karenitecin, in melanoma.

scientific article

Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics study

scientific article published on 22 June 2017

Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma

scientific article published on 31 October 2016

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma

scientific article published on 18 July 2018

Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma

scientific article

Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis

scientific article published on 01 October 2020

Removing the unknown from the carcinoma of unknown primary

scientific article published on 10 December 2012

Replacement of administration sets (including transducers) for peripheral arterial catheters: a systematic review.

scientific article

Reply to M.-E. Percival et al and L.B. Saltz.

scientific article published in July 2013

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma

scientific article

Revisiting RECIST: the case of treatment beyond progression

scientific article published on 18 January 2018

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

scientific article (publication date: 11 July 2013)

Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma.

scientific article

State of the science 60th anniversary review: 60 Years of advances in cutaneous melanoma epidemiology, diagnosis, and treatment, as reported in the journal Cancer.

scientific article published on October 2008

The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?

scientific article

The Role of Anti-PD-1/PD-L1 Agents in Melanoma: Progress to Date

scientific article published on April 2015

The State of Melanoma: Emergent Challenges and Opportunities

scientific article published on 07 January 2021

The clinical benefit of cardiac resynchronization therapy for narrow QRS compared to broad QRS complex patients

scientific article published on 26 January 2015

The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial

scientific article

The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics

scientific article published on 22 January 2014

The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma.

scientific article published on 19 July 2018

The trans fatty acid content in human milk and its association with maternal diet among lactating mothers in Malaysia.

scientific article published on January 2013

Treatment of cutaneous melanoma: current approaches and future prospects.

scientific article

Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma

scientific article published on 02 June 2020

Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma.

scientific article

Paulina is supported by:

About Paulina

Help